首页>
外文OA文献
>Effetti a lungo termine di una dieta a basso versus una dieta a moderato contenuto proteico sulla progressione della insufficienza renale cronica
【2h】
Effetti a lungo termine di una dieta a basso versus una dieta a moderato contenuto proteico sulla progressione della insufficienza renale cronica
Background: Whether low protein diet (LPD) regimens as opposed to moderate protein restrictions (MPR) improve long-term survival of Chronic Kidney Disease (CKD) patients or induce protein caloric malnutrition (PCM) remains unknown. Study Design: Intention-to-treat analysis of follow-up data from a randomized controlled trial on the metabolic effects of LPD v MPR (0.55 v 0.80 g/kg/day). Setting & Participants: 423 CKD (Stage 4-5) patients were randomized between January 1999 and January 2003, and followed until December 2006 or death. Outcomes: PCM, dialysis, death or composite outcome of dialysis and death. Measurements: Cox regression was used to model time to dialysis initiation and death as a function of protein regimen while taking into account biochemical and clinical data. Results: The average protein intakes were 0.73±0.04 g/kg/day (Gr-0.55) and 0.9±0.06 g/kg/day (Gr-0.80). After an average follow-up of 32 months (median 30 months, 1st and 3rd quartile: 21 to 39) only three patients met the criteria for PCM. The cumulative incidence of death or dialysis start were unaffected by the diet regimen, with 113 patients reaching the composite outcome: 56 (26%) patients in the Gr-0.55 and 57 (27%) patients in the Gr-0.80. Only 11% of participants died during the study, with 66% and 64% remaining dialysis and death free in the Gr-0.55 and Gr-0.80 respectively. Limitations: Secondary analysis of trial data. Conclusions: Our study shows that (1) the prescription of a low protein diet does not lead to protein wasting; (2) most patients, regularly followed in CKD clinics, remain acceptably compliant to the prescribed dietary protein intake restrictions; and (3) low protein diet does not seem to impact patient outcomes.
展开▼
机译:背景:低蛋白饮食(LPD)方案与中度蛋白限制(MPR)方案相比是否提高了慢性肾脏病(CKD)患者的长期存活率或诱导蛋白热量营养不良(PCM)仍是未知的。研究设计:对LPD v MPR(0.55 v 0.80 g / kg / day)的代谢影响的随机对照试验的随访数据进行意向分析。参加者:1999年1月至2003年1月,随机抽取423例CKD(4-5期)患者,随访至2006年12月或死亡。结果:PCM,透析,死亡或透析与死亡的综合结果。测量:Cox回归用于建模到透析开始和死亡的时间,作为蛋白质治疗的函数,同时考虑到生化和临床数据。结果:平均蛋白质摄入量为0.73±0.04 g / kg /天(Gr-0.55)和0.9±0.06 g / kg / day(Gr-0.80)。在平均随访32个月(中位数30个月,第一和第三四分位数:21至39)之后,只有3例患者符合PCM标准。饮食方案不受死亡或透析开始的累积发生率的影响,有113例患者达到综合结局:Gr-0.55的患者为56(26%),Gr-0.80的患者为57(27%)。在研究期间,只有11%的参与者死亡,而在Gr-0.55和Gr-0.80中分别有66%和64%的血液透析和无死亡。局限性:试验数据的二次分析。结论:我们的研究表明:(1)低蛋白饮食的处方不会导致蛋白质浪费; (2)大多数在CKD诊所定期接受随访的患者,仍符合规定的饮食蛋白质摄入限制标准; (3)低蛋白饮食似乎并不影响患者预后。
展开▼